Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Publikováno v:
Cancer Imaging
We report a case of unexpected heterogeneous uptake of gadoxetic acid into a hepatic metastasis in a patient with T-cell lymphoblastic lymphoma that also lacked hypermetabolic characteristics on positron emission (PET)/computed tomography (CT) with [
Publikováno v:
Cancer Imaging
A 71-year-old woman was admitted to our hospital with asthenia, weight loss, fever, cognitive impairment and shortness of breath. Physical examination showed hemiparesis and cerebellar ataxia. There was no superficial lymphadenopathy. Blood tests sho
Publikováno v:
Cancer Imaging
Castleman disease (CD) is a rare atypical lymphoproliferative disease, pathologically classified as hyaline vascular, plasma cell type and mixed type variant. The underlying cause of CD is unknown, however several theories including autoimmunity have
Autor:
Sheila Rankin
Publikováno v:
Cancer Imaging
Computed tomography (CT) and magnetic resonance imaging (MRI) are excellent modalities for the localization of mediastinal masses and there are often features that may allow the correct diagnosis to be made. However, CT and MRI cannot usually assess
Publikováno v:
Cancer Imaging
Fleming, I N, Gilbert, F J, Miles, K A & Cameron, D 2010, ' Opportunities for PET to deliver clinical benefit in cancer : breast cancer as a paradigm ', Cancer Imaging, vol. 10, no. 1, pp. 144-52 . https://doi.org/10.1102/1470-7330.2010.0020
Fleming, I N, Gilbert, F J, Miles, K A & Cameron, D 2010, ' Opportunities for PET to deliver clinical benefit in cancer : breast cancer as a paradigm ', Cancer Imaging, vol. 10, no. 1, pp. 144-52 . https://doi.org/10.1102/1470-7330.2010.0020
The glucose analogue fluorodeoxyglucose (FDG) has demonstrated enhanced uptake in the majority of tumours as a result of increased uptake and fixation by phosphorylation. It is the most widely used radiotracer in positron emission tomography (PET), b
Autor:
J Ward
Publikováno v:
Cancer Imaging
It is well established that hepatic resection improves the long-term prognosis of many patients with liver metastases. However, incomplete resection does not prolong survival, so knowledge of the exact extent of intra-hepatic disease is crucially imp
Autor:
Rodney J. Hicks
Publikováno v:
Cancer Imaging
Despite the excellent clinical performance of fluorodeoxyglucose (FDG) as a cancer-imaging agent for positron emission tomography (PET), false positive and false negative results can be problematic in some clinical settings. Radiopharmaceutical devel
Autor:
Kenneth A. Miles
Publikováno v:
Cancer Imaging
Nuclear oncology featured strongly in the 2011 issue of Cancer Imaging with 5 reviews, 2 original articles and 3 case reports. Many articles described diagnostic applications of novel or emerging tracers. Stomatostatin receptor scintigraphy provided